Open Access Journal of Clinical Trials

Scope & Guideline

Pioneering Discoveries, Shaping Medical Futures.

Introduction

Welcome to the Open Access Journal of Clinical Trials information hub, where our guidelines provide a wealth of knowledge about the journal’s focus and academic contributions. This page includes an extensive look at the aims and scope of Open Access Journal of Clinical Trials, highlighting trending and emerging areas of study. We also examine declining topics to offer insight into academic interest shifts. Our curated list of highly cited topics and recent publications is part of our effort to guide scholars, using these guidelines to stay ahead in their research endeavors.
LanguageEnglish
ISSN1179-1519
PublisherDOVE MEDICAL PRESS LTD
Support Open AccessYes
CountryNew Zealand
TypeJournal
Convergefrom 2009 to 2024
AbbreviationOPEN ACCESS J CLIN T / Open Access J. Clin. Trials
Frequency1 issue/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressPO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND

Aims and Scopes

The Open Access Journal of Clinical Trials focuses on disseminating innovative clinical research findings, methodologies, and best practices across various health disciplines. Its core areas emphasize the importance of rigorous trial designs, participant engagement, and the evaluation of health interventions.
  1. Clinical Trial Methodologies:
    The journal emphasizes the development and evaluation of various clinical trial designs, including randomized controlled trials, pilot studies, and pragmatic trials, ensuring robust methodological standards.
  2. Patient-Centric Research:
    Research focused on participant compliance, satisfaction, and engagement in clinical trials highlights the importance of patient perspectives in the design and implementation of health interventions.
  3. Interventions for Vulnerable Populations:
    A consistent focus on clinical trials targeting specific age groups or vulnerable populations, such as older adults, individuals with chronic conditions, and patients with mental health issues, showcases the journal's commitment to addressing health disparities.
  4. Translational Research:
    The journal publishes findings that bridge the gap between laboratory research and clinical practice, promoting the application of scientific discoveries in real-world settings.
  5. Holistic and Multidomain Interventions:
    Research on multifaceted interventions, particularly for chronic conditions and mental health, emphasizes the complexity of health challenges and the need for comprehensive treatment approaches.
Recent publications reflect an evolving focus within the journal, highlighting emerging themes that resonate with contemporary health challenges and research priorities.
  1. COVID-19 Related Research:
    The journal has seen a significant increase in studies related to COVID-19, including vaccine efficacy and treatment protocols, reflecting the ongoing global health crisis and the need for timely research.
  2. Mental Health Interventions:
    There is a growing emphasis on mental health, particularly interventions designed for specific populations, such as older adults with HIV, indicating a recognition of the increasing importance of mental well-being in overall health outcomes.
  3. Home-Based Healthcare Interventions:
    Research focused on home-based interventions, such as home blood pressure monitoring, is trending, showcasing a shift towards patient-centered care that empowers individuals to manage their health in familiar settings.
  4. Social Support Mechanisms:
    Emerging themes around social support interventions for chronic disease management, like diabetes, highlight the importance of community and social networks in improving health outcomes.

Declining or Waning

While the journal continues to evolve, certain themes have shown a decrease in prominence in recent publications. These waning scopes suggest shifting priorities within the clinical trial research landscape.
  1. Traditional Medicine Trials:
    Although the journal has recently published work on traditional Chinese medicine, the broader focus on alternative and complementary therapies appears to be declining, possibly due to a growing emphasis on evidence-based practices.
  2. Single-Dose Trials:
    The publication of single-dose trials has become less frequent, indicating a possible shift towards more comprehensive intervention studies that assess longer-term effects and multi-dose strategies.
  3. Niche Pharmaceutical Interventions:
    Research on specific pharmaceutical alternatives, such as the Gabapentinoid for cocaine consumption problems, has decreased, suggesting a trend towards broader health interventions rather than niche pharmaceutical solutions.

Similar Journals

Integrative Medicine Research

Connecting Researchers to Shape Holistic Health
Publisher: ELSEVIERISSN: 2213-4220Frequency: 4 issues/year

Integrative Medicine Research, published by Elsevier, is a premier journal dedicated to advancing the field of Complementary and Alternative Medicine. With an impact factor that reflects its esteemed position—ranking 15th out of 105 journals in its category as of 2023 and placing in the 86th percentile—this journal serves as a pivotal platform for researchers, professionals, and students alike. Since its transition to an Open Access model in 2012, it has enhanced the dissemination of critical research, fostering collaboration and application of integrative approaches to health and wellness. The journal encompasses a wide array of topics within its scope, encouraging submissions that contribute to the evidence base of integrative practices and their effects on health outcomes. As a quarterly publication based in South Korea, it emphasizes the importance of global perspectives in research, thereby inspiring innovation in complementary healthcare practices.

International Journal of Biostatistics

Exploring Innovations in Biostatistical Applications.
Publisher: WALTER DE GRUYTER GMBHISSN: 2194-573XFrequency: 2 issues/year

The International Journal of Biostatistics, published by Walter de Gruyter GmbH, stands as a critical platform for advancements in the fields of biostatistics and applied statistics in medicine. With an ISSN of 2194-573X and an E-ISSN of 1557-4679, this journal has gained recognition for its rigorous peer-reviewed articles that bridge theoretical statistics and its practical applications in health sciences, maintaining a commendable Q2 quartile ranking in both Medicine and Statistics categories as of 2023. Hosted in Germany, the journal's pivotal role lies in disseminating innovative research findings that guide public health decisions and inform healthcare policy, thus appealing to a diverse readership including researchers, healthcare professionals, and students. Although the journal operates under a subscription model, it remains committed to providing valuable insights into the statistical methods that support evidence-based medicine and improve health outcomes globally. For those engaged in the evolving landscape of biostatistics, the International Journal of Biostatistics serves as an indispensable resource through its comprehensive coverage from 2005 to 2024.

Danish Medical Journal

Elevating Standards in Research and Practice.
Publisher: DANISH MEDICAL ASSOCISSN: Frequency: 12 issues/year

Danish Medical Journal, published by the esteemed Danish Medical Association, is a vital platform in the field of medicine, providing open access research that reflects the current advances and innovations within the medical community. With an E-ISSN of 2245-1919, this journal has established itself as a significant contributor to the discourse in general medicine, holding a commendable Q3 rank in Scopus for 2023 and placed in the 65th percentile among its peers. The journal aims to disseminate high-quality research from Denmark and beyond, fostering collaboration and dialogue across disciplines. Researchers, healthcare professionals, and students alike will find invaluable insights into contemporary medical issues and evidence-based practices within its pages. The journal, which has successfully converged its focus from 2012 to 2024, is committed to continuing its legacy of excellence and innovation in medical literature, ensuring that readers remain at the forefront of medical science.

Complementary Therapies in Clinical Practice

Bridging the gap between conventional and alternative medicine.
Publisher: ELSEVIER SCI LTDISSN: 1744-3881Frequency: 4 issues/year

Complementary Therapies in Clinical Practice is a premier academic journal published by Elsevier Science Ltd, dedicated to advancing the field of complementary and alternative medicine. With an impressive impact factor placing it in the Q1 category for its field and a Scopus rank of 16 out of 105, it serves as a vital platform for sharing high-quality research and clinical insights. Established in 2005 and continuing through 2024, the journal is committed to disseminating evidence-based practices that enhance patient care and safety. Although it does not offer open access, the journal remains integral to researchers, clinicians, and students striving to integrate complementary therapies within conventional healthcare frameworks. Based in the United Kingdom, the journal not only promotes scholarly discourse but also fosters collaboration across an international community of practitioners dedicated to innovative therapeutic approaches.

Traditional Medicine Research

Exploring the Intersection of Ancient Wisdom and Modern Science
Publisher: TMR PUBLISHING GROUPISSN: 2413-3973Frequency: 6 issues/year

Traditional Medicine Research is a pioneering journal dedicated to advancing the field of traditional medicine through impactful research and scholarly discourse. Published by TMR Publishing Group, this Open Access journal has been committed to enhancing the accessibility of invaluable research since 2016. With its ISSN 2413-3973, it provides a platform for researchers, professionals, and students to explore and disseminate knowledge pertaining to various aspects of traditional medicinal practices, herbal therapies, and integrative healthcare solutions. Positioned to bridge the gap between ancient wisdom and modern scientific inquiry, Traditional Medicine Research plays a crucial role in fostering a deeper understanding of therapeutic traditions and their applications in contemporary health contexts. Scholars and practitioners are encouraged to engage with the latest findings, share innovative methodologies, and contribute to a vibrant community focused on the evolution and validation of traditional medicine.

Journal of the Chinese Medical Association

Elevating Standards in Medical Research and Practice
Publisher: LIPPINCOTT WILLIAMS & WILKINSISSN: 1726-4901Frequency: 12 issues/year

Journal of the Chinese Medical Association, published by LIPPINCOTT WILLIAMS & WILKINS, is a prominent peer-reviewed journal in the field of general medicine, specifically focused on advancements and research within the Chinese medical community. Established in 2003 and with a scope that spans diverse medical disciplines, this journal has positioned itself as a key resource for medical professionals, researchers, and academics interested in both clinical practices and health policy in Taiwan and the broader context of Asian medicine. With an impressive Scopus ranking of 69 out of 636 in the general medicine category and a notable percentile rank of 89th, the journal is recognized for its contributions to medical science. Although it does not currently provide open access options, it continues to maintain a robust presence through its high-quality publications and rigorous peer-review process aimed at fostering innovation and sharing critical insights across the medical field. Researchers and students alike will find this journal an invaluable platform for disseminating their findings and engaging with current medical discourse.

Functional Foods in Health and Disease

Transforming Research on Functional Foods and Wellness
Publisher: FUNCTIONAL FOOD CENTER INCISSN: 2160-3855Frequency: 12 issues/year

Functional Foods in Health and Disease is a respected peer-reviewed journal published by FUNCTIONAL FOOD CENTER INC, dedicated to advancing research in the fields of biochemistry, food science, medicine, and nutrition. Since its inception in 2011, this journal has provided a platform for innovative studies that connect the impact of functional foods on health and disease outcomes. With a focus on interdisciplinary research, it aims to disseminate knowledge that enhances the understanding of how specific food components can influence health and well-being. The journal is indexed with an ISSN of 2160-3855 and annually ranked in several categories, including Q4 in Biochemistry and Q3 in Food Science, Medicine, and Nutrition and Dietetics for 2023. As an open access publication, it ensures that research is widely accessible, which is crucial for fostering collaboration and discussion within the scientific community. This journal is a vital resource for researchers, practitioners, and students seeking to explore the dynamic role of functional foods in health promotion and disease prevention.

AMERICAN JOURNAL OF THE MEDICAL SCIENCES

Empowering healthcare through rigorous research.
Publisher: ELSEVIER SCIENCE INCISSN: 0002-9629Frequency: 12 issues/year

The American Journal of the Medical Sciences, published by Elsevier Science Inc, has been a cornerstone in the field of medicine since its inception in 1945. With ISSN 0002-9629 and E-ISSN 1538-2990, this esteemed journal provides a comprehensive forum for the dissemination of cutting-edge research and clinical advancements across various medical disciplines. It currently holds a distinguished Q2 ranking in the field of Medicine (miscellaneous) and ranks #118 out of 636 in General Medicine on Scopus, reflecting its significant impact with an 81st percentile rating. While it operates under a traditional publishing model, which ensures rigorous peer-review processes, its commitment to disseminating vital medical knowledge remains paramount. Based in the United States at STE 800, 230 Park Ave, New York, NY 10169, the journal aims to bridge the gap between research and practice, making it an invaluable resource for researchers, healthcare professionals, and students dedicated to advancing medical science and improving patient care.

Trials

Exploring new frontiers in clinical research and methodology.
Publisher: BMCISSN: Frequency: 1 issue/year

Trials, published by BMC, is a leading open access journal that has been pioneering advancements in the field of medicine and pharmacology since its inception in 2006. With an impressive E-ISSN of 1745-6215, the journal is based in the United Kingdom and operates from its address at CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND. Trials is recognized for its impactful contributions to the research community, achieving a Q2 ranking in both the Medicine (miscellaneous) and Pharmacology (medical) categories according to the 2023 category quartiles. This esteemed journal aims to provide a platform for presenting cutting-edge clinical trials and methodological advances, effectively fostering collaboration and innovation among researchers, professionals, and students. The journal's accessibility, supported by its open access model, enhances the visibility and dissemination of vital research findings, ensuring that every contribution reaches a broad audience. As of 2024, Trials continues to be a crucial resource for anyone passionate about exploring new frontiers in medical research.

Therapeutic Innovation & Regulatory Science

Leading the Charge in Therapeutic and Regulatory Science
Publisher: SPRINGER HEIDELBERGISSN: 2168-4790Frequency: 6 issues/year

Therapeutic Innovation & Regulatory Science, published by Springer Heidelberg, is an esteemed journal that focuses on the intersection of therapeutic innovations and the regulatory frameworks that govern them. Established in 1970 and continuing its legacy of excellence through converged years, this journal plays a crucial role in supplying cutting-edge research, reviews, and discussions that advance understanding in the fields of pharmacology and healthcare regulation. With an impact factor reflective of its rigorous peer-review standards, this journal holds a prestigious Q1 ranking in Pharmacology, Toxicology, and Pharmaceutics (Miscellaneous) for 2023, reflecting its influence and the high quality of its published material. The journal's wide scope also embraces public health and environmental studies, making it an essential resource for researchers and professionals navigating these critical areas. Open access options enhance its visibility and accessibility, ensuring that the latest discoveries and regulatory insights are readily available to a global audience. For those at the forefront of medicinal science and regulatory affairs, Therapeutic Innovation & Regulatory Science is your avenue to understanding pivotal innovations that shape contemporary therapeutic practices.